Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 1 | 4 | 2022 | 567 | 1.940 |
Why?
|
| Blood Glucose Self-Monitoring | 3 | 2022 | 57 | 1.480 |
Why?
|
| Blood Glucose | 5 | 2022 | 873 | 1.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2023 | 1373 | 1.010 |
Why?
|
| Diabetes Mellitus | 4 | 2023 | 806 | 0.860 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2023 | 247 | 0.750 |
Why?
|
| Appointments and Schedules | 2 | 2023 | 53 | 0.730 |
Why?
|
| Telemedicine | 2 | 2020 | 169 | 0.710 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2020 | 55 | 0.690 |
Why?
|
| Insulin Infusion Systems | 1 | 2018 | 36 | 0.660 |
Why?
|
| Cost-Benefit Analysis | 5 | 2022 | 454 | 0.640 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 351 | 0.580 |
Why?
|
| Inpatients | 1 | 2020 | 297 | 0.580 |
Why?
|
| Insulin | 2 | 2018 | 1160 | 0.570 |
Why?
|
| Hypertension | 1 | 2022 | 1141 | 0.460 |
Why?
|
| Quality of Life | 4 | 2023 | 1585 | 0.450 |
Why?
|
| Population Health | 2 | 2023 | 33 | 0.440 |
Why?
|
| Primary Health Care | 5 | 2024 | 339 | 0.410 |
Why?
|
| Asthma | 1 | 2020 | 955 | 0.410 |
Why?
|
| Hypothyroidism | 2 | 2023 | 232 | 0.390 |
Why?
|
| Adult | 13 | 2023 | 25648 | 0.390 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2022 | 138 | 0.380 |
Why?
|
| Ambulatory Care Facilities | 2 | 2022 | 102 | 0.360 |
Why?
|
| Medicaid | 2 | 2024 | 217 | 0.350 |
Why?
|
| Delivery of Health Care | 2 | 2024 | 426 | 0.340 |
Why?
|
| Cross-Sectional Studies | 6 | 2024 | 1621 | 0.340 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2023 | 238 | 0.330 |
Why?
|
| Humans | 28 | 2024 | 86644 | 0.330 |
Why?
|
| Depression | 5 | 2023 | 473 | 0.320 |
Why?
|
| Community Health Centers | 3 | 2023 | 113 | 0.310 |
Why?
|
| United States | 6 | 2024 | 6672 | 0.260 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 2 | 2022 | 35 | 0.260 |
Why?
|
| Triiodothyronine | 2 | 2023 | 339 | 0.250 |
Why?
|
| Thyroxine | 2 | 2023 | 344 | 0.250 |
Why?
|
| Aged | 8 | 2023 | 18415 | 0.230 |
Why?
|
| Thyroid Hormones | 2 | 2023 | 321 | 0.230 |
Why?
|
| Patient Portals | 1 | 2023 | 15 | 0.230 |
Why?
|
| Physicians | 2 | 2023 | 673 | 0.230 |
Why?
|
| Patient Care Bundles | 1 | 2023 | 20 | 0.230 |
Why?
|
| Hypoglycemic Agents | 3 | 2022 | 378 | 0.210 |
Why?
|
| Hyperthyroidism | 1 | 2022 | 75 | 0.210 |
Why?
|
| Office Visits | 1 | 2022 | 44 | 0.210 |
Why?
|
| Hormone Replacement Therapy | 1 | 2022 | 77 | 0.200 |
Why?
|
| Social Determinants of Health | 1 | 2022 | 78 | 0.200 |
Why?
|
| Health Care Costs | 1 | 2023 | 238 | 0.200 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2022 | 103 | 0.200 |
Why?
|
| Patient Outcome Assessment | 1 | 2022 | 84 | 0.200 |
Why?
|
| Psychiatry | 1 | 2022 | 78 | 0.190 |
Why?
|
| Metformin | 1 | 2022 | 128 | 0.190 |
Why?
|
| Financing, Organized | 1 | 2020 | 12 | 0.190 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2020 | 22 | 0.190 |
Why?
|
| Male | 8 | 2023 | 40966 | 0.180 |
Why?
|
| Health Services Accessibility | 2 | 2021 | 394 | 0.180 |
Why?
|
| Chronic Pain | 1 | 2022 | 145 | 0.180 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 161 | 0.180 |
Why?
|
| Adolescent | 3 | 2022 | 8981 | 0.180 |
Why?
|
| Colorado | 1 | 2019 | 35 | 0.180 |
Why?
|
| Comparative Effectiveness Research | 1 | 2020 | 53 | 0.170 |
Why?
|
| Intention to Treat Analysis | 1 | 2019 | 72 | 0.170 |
Why?
|
| Female | 8 | 2023 | 44533 | 0.170 |
Why?
|
| Physicians, Primary Care | 1 | 2020 | 104 | 0.170 |
Why?
|
| Allied Health Personnel | 1 | 2018 | 19 | 0.160 |
Why?
|
| Monitoring, Ambulatory | 1 | 2018 | 32 | 0.160 |
Why?
|
| Middle Aged | 5 | 2022 | 25028 | 0.160 |
Why?
|
| Job Satisfaction | 1 | 2018 | 73 | 0.150 |
Why?
|
| Feasibility Studies | 1 | 2020 | 751 | 0.150 |
Why?
|
| Hypoglycemia | 1 | 2018 | 107 | 0.150 |
Why?
|
| Prospective Studies | 2 | 2023 | 4214 | 0.150 |
Why?
|
| Substance-Related Disorders | 1 | 2020 | 394 | 0.140 |
Why?
|
| Hospitals | 3 | 2023 | 294 | 0.140 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 2705 | 0.140 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 455 | 0.130 |
Why?
|
| Electronic Health Records | 1 | 2018 | 319 | 0.130 |
Why?
|
| Hospitalization | 3 | 2024 | 849 | 0.120 |
Why?
|
| Nutrition Surveys | 2 | 2023 | 114 | 0.110 |
Why?
|
| Thyrotropin | 2 | 2023 | 280 | 0.100 |
Why?
|
| Sodium | 2 | 2022 | 341 | 0.100 |
Why?
|
| Young Adult | 2 | 2019 | 5976 | 0.090 |
Why?
|
| Glucose | 2 | 2022 | 638 | 0.090 |
Why?
|
| Pilot Projects | 2 | 2022 | 839 | 0.080 |
Why?
|
| Attitude of Health Personnel | 2 | 2022 | 636 | 0.060 |
Why?
|
| Diagnosis-Related Groups | 1 | 2023 | 20 | 0.060 |
Why?
|
| Maryland | 1 | 2023 | 35 | 0.060 |
Why?
|
| Demography | 1 | 2023 | 177 | 0.060 |
Why?
|
| Housing | 1 | 2023 | 42 | 0.060 |
Why?
|
| Thyroid Function Tests | 1 | 2023 | 119 | 0.060 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2022 | 9 | 0.060 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2022 | 48 | 0.050 |
Why?
|
| Telephone | 1 | 2022 | 32 | 0.050 |
Why?
|
| Rural Population | 1 | 2023 | 136 | 0.050 |
Why?
|
| Data Collection | 1 | 2023 | 372 | 0.050 |
Why?
|
| Poverty | 1 | 2023 | 173 | 0.050 |
Why?
|
| Social Support | 1 | 2023 | 193 | 0.050 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2022 | 166 | 0.050 |
Why?
|
| Opiate Substitution Treatment | 1 | 2020 | 30 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2024 | 484 | 0.050 |
Why?
|
| Medicare | 1 | 2023 | 410 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2023 | 971 | 0.040 |
Why?
|
| Length of Stay | 1 | 2022 | 702 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2023 | 428 | 0.040 |
Why?
|
| Emotions | 1 | 2022 | 341 | 0.040 |
Why?
|
| Patient Selection | 1 | 2022 | 685 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 413 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2022 | 582 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2023 | 2767 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2261 | 0.030 |
Why?
|
| Child | 1 | 2024 | 6927 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 2501 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2022 | 7993 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2022 | 8489 | 0.020 |
Why?
|